SCHEMBL1244142

SCHEMBL1244142

C=Cc1coc2cc(C(=O)O)[nH]c12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 5/20 0.59
ALOX15 P16050 1/20 0.36
NFKB1 P19838 1/20 0.36
BLM P54132 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP2C19 P33261 1/20 0.35
GPR35 Q9HC97 3/20 0.35
HPGD P15428 4/20 0.35
KDM4E B2RXH2 4/20 0.35
ALDH1A1 P00352 3/20 0.35
LMNA P02545 2/20 0.35
HSD17B10 Q99714 2/20 0.34
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
IDO1 P14902 1/20 0.32
TDO2 P48775 1/20 0.32
APEX1 P27695 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1244885 0.85 DAO (0.61) DAOALOX15NFKB1BLMSMN1; SMN2
SCHEMBL1242703 0.81 DAO (0.56) DAOALOX15NFKB1BLMSMN1; SMN2
SCHEMBL1242700 0.81 DAO (0.56) DAOALOX15NFKB1BLMSMN1; SMN2
SCHEMBL1245203 0.79 ALDH1A1 (0.40) DAOALOX15SMN1; SMN2HPGDKDM4E
SCHEMBL1244700 0.78 DAO (0.53) DAOHPGDKDM4EALDH1A1HSD17B10
SCHEMBL1244698 0.78 DAO (0.53) DAOHPGDKDM4EALDH1A1HSD17B10
SCHEMBL1244762 0.75 DAO (1.00) DAOALOX15NFKB1BLMSMN1; SMN2
SCHEMBL1244217 0.75 DAO (0.65) DAOALOX15NFKB1BLMSMN1; SMN2
SCHEMBL1242714 0.75 DAO (0.65) DAOALOX15NFKB1BLMSMN1; SMN2
SCHEMBL1244731 0.75 DAO (0.65) DAOALOX15NFKB1BLMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7884124-B2 such as 2-Fluoro-4H-furo[3,2-b]pyrrole-5-carboxylate acid, used for the treatment of neuropathic pain, Alzheimer's disease, schizophrenia, ataxia and convulsions SEPRACOR INC. (US) 2011-02-08 US disclosed
US-7884124-B2 such as 2-Fluoro-4H-furo[3,2-b]pyrrole-5-carboxylate acid, used for the treatment of neuropathic pain, Alzheimer's disease, schizophrenia, ataxia and convulsions SEPRACOR INC. (US) 2011-02-08 US disclosed
US-7884124-B2 such as 2-Fluoro-4H-furo[3,2-b]pyrrole-5-carboxylate acid, used for the treatment of neuropathic pain, Alzheimer's disease, schizophrenia, ataxia and convulsions SEPRACOR INC. (US) 2011-02-08 US disclosed
US-20100029741-A1 FUSED HETEROCYCLES SEPRACOR INC. (US) 2010-02-04 US disclosed
US-20100022612-A1 FUSED HETEROCYCLES SEPRACOR INC. (US) 2010-01-28 US disclosed
US-7579370-B2 Fused heterocycles SEPRACOR INC. (US) 2009-08-25 US disclosed
US-20080058395-A1 Fused heterocyclic inhibitors of D-amino acid oxidase SEPRACOR INC. (US) 2008-03-06 US disclosed
US-20080058395-A1 Fused heterocyclic inhibitors of D-amino acid oxidase SEPRACOR INC. (US) 2008-03-06 US disclosed
WO-2008005456-A2 FUSED HETEROCYCLIC INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2008-01-10 WO disclosed
US-20080004327-A1 FLUORO-SUBSTITUTED INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2008-01-03 US disclosed
US-20080004327-A1 FLUORO-SUBSTITUTED INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2008-01-03 US disclosed
US-20080004327-A1 FLUORO-SUBSTITUTED INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2008-01-03 US disclosed
US-20080004328-A1 FUSED HETEROCYCLES SEPRACOR INC. (US) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022612-A1 FUSED HETEROCYCLES AHR, HAX1, HRH3 DAO 2452/4885ALOX15 4030/4885NFKB1 3401/4885
US-20080058395-A1 Fused heterocyclic inhibitors of D-amino acid oxidase DAO, DDO, AOX1 DAO 1/4885ALOX15 622/4885NFKB1 2943/4885
US-20100029741-A1 FUSED HETEROCYCLES CHRNA4, CHRNB4, CHRNA3 DAO 1545/4885ALOX15 2795/4885NFKB1 3738/4885
US-20080004328-A1 FUSED HETEROCYCLES HRH3, HRH4, AHR DAO 2936/4885ALOX15 4295/4885NFKB1 3054/4885
US-20080004327-A1 FLUORO-SUBSTITUTED INHIBITORS OF D-AMINO ACID OXIDASE DAO, DDO, AOX1 DAO 1/4885ALOX15 776/4885NFKB1 3914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.